The new platform combines M42’s advanced AI capabilities with Diaverum’s 35 years of renal care expertise to make trusted, personalized kidney-health education more accessible worldwide
Explore MoreM42, a global health leader powered by artificial intelligence (AI), technology and genomics, has been recognized by the Ministry of Health and Prevention (MoHAP)
Explore MoreM42 is strengthening its UAE healthcare portfolio with 100 per cent ownership of United Eastern Medical Services’ assets, while Olive Rock Partners takes 100 per cent ownership of HealthPlus IVF & Women’s Health Abu Dhabi
Explore MoreLaunch groundbreaking effort to advance precision medicine by delivering pharmacogenomic insight at the point of care
Explore MoreM42 formalizes its 12-year presence in the Kingdom at the Global Health Exhibition in Riyadh, reinforcing alignment with Vision 2030 and commitment to preventive, data-driven healthcare
Explore MoreOver 100,000 pediatric consultations and children outpatient visits across Danat Al Emarat Women & Children’s Hospital, HealthPl...
New multidisciplinary clinic coordinates surgical, dental, hearing and speech services from infancy through adulthood
Abu Dhabi Biobank, a strategic initiative between the Department of Health, Abu Dhabi (DoH), and global health leader M42, has r...
ICLDEC commemorated two decades of advancing diabetes and endocrine care in the UAE, celebrating its journey from a specialist d...
M42 to apply genomic testing and research to support more personalized early intervention for children with neurodevelopmental c...
The two-day conference brought together local and international healthcare experts to advance knowledge-sharing and collaboratio...